The Oslo Cancer Cluster actively supports the Norwegian Cancer Genomics Consortium (NCGC), and has done so since the start.
The Oslo Cancer Cluster Management Team in close collaboration with several members, was vital in supporting the birth of the NCGC and is actively promoting the consortium and its activities through its meeting places and networks – both national and international.
Personalized Cancer Medicine is an area of great importance for the Oslo Cancer Cluster, and one of the major projects we work on. The area is of key importance for all member groups, from academic researchers, to clinicians, biotech and pharma companies developing novel cancer treatments in preclinical and clinical research. A personal approach to cancer care improves patient care, and tailored treatment based on individual diagnostics, can address existing and future challenges of our health care system.